<p>，/PRNewswire/ -- 律師廣告 -- 全國知名律師事務所 Bronstein, Gewirtz &amp; Grossman, LLC 通知投資者，針對 LifeMD, Inc.（&#34;LifeMD&#34;或&#34;公司&#34;）（NASDAQ: LFMD）及其部分高管提起了集體訴訟。</p>
<p><strong>集體定義</strong></p>
<p>本訴訟旨在代表所有在 2025 年 5 月 7 日至 2025 年 8 月 5 日（包括這兩個日期）期間購買或以其他方式獲得 LifeMD 證券的個人和實體，向被告索賠，因其涉嫌違反聯邦證券法。鼓勵此類投資者通過訪問該事務所網站加入此案：bgandg.com/LFMD。</p>
<p><strong>案件詳情</strong></p>
<p>投訴書指控被告作出了虛假和/或誤導性的陳述，和/或未能披露以下內容：（1）被告嚴重誇大了 LifeMD 的競爭地位；（2）被告在提高 LifeMD 的 2025 年指導時表現出魯莽，因為他們沒有正確考慮 LifeMD 的 RexMD 部門客户獲取成本的上升，以及與銷售旨在治療肥胖的藥物（包括 Wegovy 和 Zepbound）相關的客户獲取成本；（3）因此，被告關於 LifeMD 的業務、運營和前景的陳述在所有相關時間都是嚴重虛假和誤導的，且/或缺乏合理依據。</p>
<p><strong>接下來會發生什麼？</strong></p>
<p>集體訴訟已經提起。如果您希望查看投訴書的副本，可以訪問該事務所網站：bgandg.com/LFMD。或者您可以聯繫 Bronstein, Gewirtz &amp; Grossman, LLC 的 Peretz Bronstein 律師或其客户關係經理 Nathan Miller，電話 332-239-2660。如果您在 LifeMD 中遭受損失，您有直到 2025 年 10 月 27 日的時間請求法院任命您為首席原告。您分享任何賠償的能力並不要求您擔任首席原告。</p>
<p><strong>您無需支付費用</strong></p>
<p>我們以風險代理的方式代表投資者進行集體訴訟。這意味着我們將請求法院報銷我們的自付費用和律師費，通常是總賠償金額的一定比例，僅在我們成功的情況下。</p>
<p><strong>為什麼選擇 Bronstein, Gewirtz &amp; Grossman</strong></p>
<p>Bronstein, Gewirtz &amp; Grossman, LLC 是一家全國知名的律師事務所，代表投資者進行證券欺詐集體訴訟和股東派生訴訟。我們的事務所為全國投資者追回了數億美元。</p>
<p>請在 LinkedIn、X、Facebook 或 Instagram 上關注我們以獲取更新。</p>
<p>律師廣告。以往結果不保證類似結果。</p>
<p><strong>聯繫方式</strong></p>
<p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
<p>Peretz Bronstein 或 Nathan Miller</p>
<p>332-239-2660 | [email protected]</p>
<p>來源：Bronstein, Gewirtz &amp; Grossman, LLC</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTAxJk5ld3NJdGVtSWQ9REM2MTUyNyZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MDExMjAwUFJfTkVXU19VU1BSX19fX19EQzYxNTI3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTAxJk5ld3NJdGVtSWQ9REM2MTUyNyZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MDExMjAwUFJfTkVXU19VU1BSX19fX19EQzYxNTI3"/></p>

LFMD

<p>Bronstein, Gewirtz & Grossman, LLC 宣佈對 LifeMD, Inc.（納斯達克代碼：LFMD）提起集體訴訟，指控其違反聯邦證券法。該訴訟旨在為在 2025 年 5 月 7 日至 2025 年 8 月 5 日期間購買 LifeMD 證券的投資者追回損失。投訴稱，LifeMD 的高管對公司的競爭地位和財務指引做出了誤導性陳述。鼓勵投資者在 2025 年 10 月 27 日截止日期之前聯繫該公司加入訴訟</p>

<p>, /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz &amp; Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (&#34;LifeMD&#34; or &#34;the Company&#34;) (NASDAQ: LFMD) and certain of its officers.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- 律師廣告 -- 全國知名律師事務所 Bronstein, Gewirtz &amp; Grossman, LLC 通知投資者，針對 LifeMD, Inc.（&#34;LifeMD&#34;或&#34;公司&#34;）（NASDAQ: LFMD）及其部分高管提起了集體訴訟。</p>
</div><p><strong>Class Definition</strong></p>
<div class="lb-trans"><p><strong>集體定義</strong></p>
</div><p>This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired LifeMD securities between May 7, 2025 and August 5, 2025, both dates inclusive (the &#34;Class Period&#34;). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/LFMD.</p>
<div class="lb-trans"><p>本訴訟旨在代表所有在 2025 年 5 月 7 日至 2025 年 8 月 5 日（包括這兩個日期）期間購買或以其他方式獲得 LifeMD 證券的個人和實體，向被告索賠，因其涉嫌違反聯邦證券法。鼓勵此類投資者通過訪問該事務所網站加入此案：bgandg.com/LFMD。</p>
</div><p><strong>Case Details</strong></p>
<div class="lb-trans"><p><strong>案件詳情</strong></p>
</div><p>The complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendants materially overstated LifeMD's competitive position; (2) Defendants were reckless in raising LifeMD's 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD's RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound; and (3) as a result, Defendants' statements about LifeMD's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.</p>
<div class="lb-trans"><p>投訴書指控被告作出了虛假和/或誤導性的陳述，和/或未能披露以下內容：（1）被告嚴重誇大了 LifeMD 的競爭地位；（2）被告在提高 LifeMD 的 2025 年指導時表現出魯莽，因為他們沒有正確考慮 LifeMD 的 RexMD 部門客户獲取成本的上升，以及與銷售旨在治療肥胖的藥物（包括 Wegovy 和 Zepbound）相關的客户獲取成本；（3）因此，被告關於 LifeMD 的業務、運營和前景的陳述在所有相關時間都是嚴重虛假和誤導的，且/或缺乏合理依據。</p>
</div><p><strong>What's Next?</strong></p>
<div class="lb-trans"><p><strong>接下來會發生什麼？</strong></p>
</div><p>A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/LFMD. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz &amp; Grossman, LLC at 332-239-2660. If you suffered a loss in LifeMD you have until October 27, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.</p>
<div class="lb-trans"><p>集體訴訟已經提起。如果您希望查看投訴書的副本，可以訪問該事務所網站：bgandg.com/LFMD。或者您可以聯繫 Bronstein, Gewirtz &amp; Grossman, LLC 的 Peretz Bronstein 律師或其客户關係經理 Nathan Miller，電話 332-239-2660。如果您在 LifeMD 中遭受損失，您有直到 2025 年 10 月 27 日的時間請求法院任命您為首席原告。您分享任何賠償的能力並不要求您擔任首席原告。</p>
</div><p><strong>There is No Cost to You</strong></p>
<div class="lb-trans"><p><strong>您無需支付費用</strong></p>
</div><p>We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.</p>
<div class="lb-trans"><p>我們以風險代理的方式代表投資者進行集體訴訟。這意味着我們將請求法院報銷我們的自付費用和律師費，通常是總賠償金額的一定比例，僅在我們成功的情況下。</p>
</div><p><strong>Why Bronstein, Gewirtz &amp; Grossman</strong></p>
<div class="lb-trans"><p><strong>為什麼選擇 Bronstein, Gewirtz &amp; Grossman</strong></p>
</div><p>Bronstein, Gewirtz &amp; Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.</p>
<div class="lb-trans"><p>Bronstein, Gewirtz &amp; Grossman, LLC 是一家全國知名的律師事務所，代表投資者進行證券欺詐集體訴訟和股東派生訴訟。我們的事務所為全國投資者追回了數億美元。</p>
</div><p>Follow us for updates on LinkedIn, X, Facebook, or Instagram.</p>
<div class="lb-trans"><p>請在 LinkedIn、X、Facebook 或 Instagram 上關注我們以獲取更新。</p>
</div><p>Attorney advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>律師廣告。以往結果不保證類似結果。</p>
</div><p><strong>Contact</strong></p>
<div class="lb-trans"><p><strong>聯繫方式</strong></p>
</div><p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
<div class="lb-trans"><p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
</div><p>Peretz Bronstein or Nathan Miller</p>
<div class="lb-trans"><p>Peretz Bronstein 或 Nathan Miller</p>
</div><p>332-239-2660 | [email protected]</p>
<div class="lb-trans"><p>332-239-2660 | [email protected]</p>
</div><p>SOURCE Bronstein, Gewirtz &amp; Grossman, LLC</p>
<div class="lb-trans"><p>來源：Bronstein, Gewirtz &amp; Grossman, LLC</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTAxJk5ld3NJdGVtSWQ9REM2MTUyNyZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MDExMjAwUFJfTkVXU19VU1BSX19fX19EQzYxNTI3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC61527&amp;Transmission_Id=202509011200PR_NEWS_USPR_____DC61527&amp;DateId=20250901"/></p>

12:00 ET
			
			
				LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

LifeMD 投資者警報：Bronstein, Gewirtz & Grossman LLC 宣佈，LifeMD, Inc.的投資者如果遭受重大損失，有機會主導集體訴訟